Simulations Plus, Inc. (NASDAQ:SLP) Q2 2024 Earnings Call Transcript
Simulations Plus, Inc. beats earnings expectations. Reported EPS is $0.1983, expectations were $0.18. Simulations Plus, Inc.
Source: insidermonkey.com
Physiologically Based Pharmacokinetics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Physiologically Based Pharmacokinetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Physiologically Based Pharmacokinetics Today - Breaking & Trending Today
Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results
Total revenue of $18.3 million and diluted earnings per share of $0.20 Maintains full-year revenue guidance of $66 to $69 million and EPS guidance of $0.66 to $0.68 ...
Source: marketscreener.com
Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results
Simulations Plus, Inc. ("Simulations Plus"), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its second quarter fiscal 2024, ended February 29, 2024....
Source: lelezard.com
Simulations Plus Inc (SLP) Reports Strong Start to Fiscal 2024 with Robust Revenue Growth
First Quarter Results Show Significant Increases in Software Revenue and EPS
Source: yahoo.com
Simulations Plus, Inc. (NASDAQ:SLP) Q1 2024 Earnings Call Transcript
Simulations Plus, Inc. misses on earnings expectations. Reported EPS is $0.09591 EPS, expectations were $0.11.
Source: insidermonkey.com